Provider: Thomson Reuters Stock Report
Provider: Thomson Reuters StreetEvents
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
3i Group PLC In Talks To Sell Pharma Firm Xellia-Reuters
Reuters reported that 3i Group PLC is in discussions to sell pharmaceutical company Xellia which could fetch around EUR750 million ($974.66 million). Linklaters is acting as legal adviser to 3i. A 3i spokesperson was not available for comment. Linklaters did not immediately return a request for comment.
Latest Developments for 3i Group PLC
- 3i Group PLC Announces Completion Of Acquisition Of Barclays Infrastructure Funds Management Limited From Barclays Bank PLC
- 3i Group PLC Announces To Offer BIFM-Business Standard
- 3i Group PLC Announces Offer To Acquire Barclays Bank plc's Infrastructure Fund Management Business
- Ferrovial SA To Acquire 3i Group PLC's Enterprise-Reuters
Latest Key Developments in Investment
- Share this
- Digg this